Boothbay Fund Management’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Other funds holding PMVP
BCM
EC
Boothbay Fund Management's PMVP Position: Q3 2026 in Review
Boothbay Fund Management held its PMV Pharmaceuticals (PMVP) position steady in Q3 2026 at 27,126 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.
Boothbay Fund Management first reported a position in PMVP in Q3 2025 and has held it in 5 quarters since. The position peaked at $282K in Q3 2025. 65 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.
- Boothbay Fund Management held 27,126 shares of PMV Pharmaceuticals worth $45.3K as of Q3 2026.
- Boothbay Fund Management left its PMV Pharmaceuticals share count unchanged in Q3 2026.
- PMV Pharmaceuticals made up ﹤0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1862 holding.
- Boothbay Fund Management first reported a position in PMV Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Boothbay Fund Management's PMV Pharmaceuticals position peaked at $282K in Q3 2025.
- 65 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.